Predict your next investment

Mp Biomedicals company logo
Corporation
HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment
mpbio.com

See what CB Insights has to offer

Investments

3

Partners & Customers

3

About Mp Biomedicals

Mp Biomedicals is a medical device company. It had developed the Mp Rapidoxy Test Strip, Model 07rd-7073.

Mp Biomedicals Headquarter Location

9418 Lasaine Ave.

Northridge, California, 91325,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Mp Biomedicals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Mp Biomedicals in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

Mp Biomedicals Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Mp Biomedicals Rank

Latest Mp Biomedicals News

Paediatric & Neonatal Testing Kits Market 2021 Past Research, Deep Analysis & Global Forecast to 2031

Oct 20, 2021

Paediatric & Neonatal Testing Kits Market 2021 Past Research, Deep Analysis & Global Forecast to 2031 Paediatric & Neonatal Testing Kits  market players – PerkinElmer Inc., Trivitron Healthcare, Natus Medical Incorporated, Medtronic Plc, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc, GE Healthcare, ZenTech S.A., MP BIOMEDICALS, Baebies, Inc., Masimo CareDx Inc., Thermo Fisher Scientific, among others represent the global Paediatric & Neonatal Testing Kits market. The market study depicts an extensive analysis of all the players running in the Paediatric & Neonatal Testing Kits market report based on distribution channels, local network, innovative launches, industrial penetration, production methods, and revenue generation. Further, the market strategies and mergers & acquisitions associated with the players are enclosed in the Paediatric & Neonatal Testing Kits market report. Future Market Insights, in its latest business report, elaborates on the current situation of the global Paediatric & Neonatal Testing Kits market in terms of volume, value, production, and consumption. The report scrutinizes the market into various segments, end uses, regions, and players on the basis of demand patterns, and future prospects. Understanding the Impact of Covid-19 on Healthcare Industry With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’. The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance. The FMI’s latest report on the Paediatric & Neonatal Testing Kits market gives a detailed analysis on the impact of COVID-19 with an incisive coverage on the innovative strategies adopted by the market players to survive the challenges due to pandemic. Request For Table Of Content @  https://www.futuremarketinsights.com/toc/rep-gb-13897 Paediatric & Neonatal Testing Kits Market: Segmentation By Product: Others Critical Questions Answered in the Report What are ongoing trends that will shape market growth curve for global Paediatric & Neonatal Testing Kits market? What are the drivers and challenges affecting the Paediatric & Neonatal Testing Kits market demand? What are the recent technological advancement in the Paediatric & Neonatal Testing Kits market? What are key trends and opportunities that will prevail the revenue growth of Paediatric & Neonatal Testing Kits market players? How will evolving regulatory policies impact the market growth? What is the impact of Covid-19 on the Paediatric & Neonatal Testing Kits market? Request For Sample Report @  https://www.futuremarketinsights.com/reports/sample/rep-gb-13897 Why Future Market Insights? Detailed insights of market segments and sub-segments for historical as well as forecast period A competitive analysis of prominent players and emerging players in the Paediatric & Neonatal Testing Kits market Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario About FMI Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers. Contact Jumeirah Lakes Towers, Dubai,

Mp Biomedicals Investments

3 Investments

Mp Biomedicals has made 3 investments. Their latest investment was in BioStratum as part of their Unattributed VC - III on August 8, 2003.

CBI Logo

Mp Biomedicals Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/15/2003

Unattributed VC - III

BioStratum

$9.5M

No

4/18/2002

Series B

Subscribe to see more

$99M

Subscribe to see more

0

3/7/2000

Unattributed VC - II

Subscribe to see more

$99M

Subscribe to see more

0

Date

8/15/2003

4/18/2002

3/7/2000

Round

Unattributed VC - III

Series B

Unattributed VC - II

Company

BioStratum

Subscribe to see more

Subscribe to see more

Amount

$9.5M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

0

0

Mp Biomedicals Partners & Customers

3 Partners and customers

Mp Biomedicals has 3 strategic partners and customers. Mp Biomedicals recently partnered with Agency for Science, Technology and Research on July 7, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

7/27/2020

Partner

Agency for Science, Technology and Research

Singapore

MP Biomedicals and A*Star Singapore Co-develop Rapid Antibody Point-of-Care Test Kit for SARS-CoV-2.

Singapore , July 27 , 2020 - MP Biomedicals announced the successful development of a rapid antibody test kit for COVID-19 , in collaboration with the Agency of Science , Technology and Research Singapore .

1

7/24/2018

Licensor, and Licensee

Biotium, Quartzy, and BioLINE

United States, and Canada

Subscribe to see more

Subscribe to see more

10

5/12/2018

Partner

Azelis

Belgium

Subscribe to see more

Subscribe to see more

10

Date

7/27/2020

7/24/2018

5/12/2018

Type

Partner

Licensor, and Licensee

Partner

Business Partner

Agency for Science, Technology and Research

Biotium, Quartzy, and BioLINE

Azelis

Country

Singapore

United States, and Canada

Belgium

News Snippet

MP Biomedicals and A*Star Singapore Co-develop Rapid Antibody Point-of-Care Test Kit for SARS-CoV-2.

Singapore , July 27 , 2020 - MP Biomedicals announced the successful development of a rapid antibody test kit for COVID-19 , in collaboration with the Agency of Science , Technology and Research Singapore .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

Mp Biomedicals Team

2 Team Members

Mp Biomedicals has 2 team members, including former Chief Executive Officer, Todd R. Nelson.

Name

Work History

Title

Status

Todd R. Nelson

Chief Executive Officer

Former

Tom Stankovich

Response Genetics, Cobalis, and Bausch Health

Chief Financial Officer

Former

Name

Todd R. Nelson

Tom Stankovich

Work History

Response Genetics, Cobalis, and Bausch Health

Title

Chief Executive Officer

Chief Financial Officer

Status

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.